Processa Pharmaceuticals, Inc. (PCSA) NASDAQ
3.16
+0.003(+0.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.47M |
| Enterprise Value | -62,014 |
| P/E Ratio | -0.46 |
| PEG Ratio | -1.45 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.08 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.13 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.66 |
| Return On Equity | -2.46 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -13.56M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 5.54M |
| Total Cash/Share | 2.91 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.54 |
| Book Value Per Share | 2.93 |
Price History
| 52-Week Change | -70.27 |
| 52-Week High | 19.63 |
| 52-Week Low | 1.76 |
| Moving Average 50 Days | 2.78 |
| Moving Average 200 Days | 5.38 |
Statistics
| Average Volume | 94,750 |
| Shares Outstanding | 2.27M |
| % Held by Institutions | 4.19 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | December 17, 2025 |
